Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1976-08-19
1977-09-13
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
424199, A61K 3114, A61K 31685
Patent
active
040483355
ABSTRACT:
1-(N-isopropyl-N,N-dimethylamino)-3-(1-naphthoxy)propan-2-ol quaternary salts are useful cardiovascular agents as evidenced by their potent and long-acting anti-arrhythmic, anti-fibrillatory and myocardial ischemia-inhibitory activity. They, furthermore, lack the undesirable side-effects, e.g. .beta.-adrenergic receptor blocking and local anesthetic activity, characteristic of related prior art compounds.
REFERENCES:
patent: 3452102 (1969-06-01), Lednicer
patent: 3658815 (1972-04-01), Fouche
McDonnell John J.
Meyers Albert T.
Stephens Daren M.
The Regents of the University of Michigan
LandOfFree
Method of inhibiting myocardial ischemia in mammals using quater does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting myocardial ischemia in mammals using quater, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting myocardial ischemia in mammals using quater will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-274833